Lista de obras -

A French National Survey on Clotting Disorders in Mastocytosis

artículo científico publicado en 2015

A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro

artículo científico publicado en 2013

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

scientific article published on 21 January 2014

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

artículo científico publicado en 2016

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets

artículo científico publicado en 2015

Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score

artículo científico publicado en 2017

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

artículo científico publicado en 2013

Be ever cautious until the truth is proven

artículo científico publicado en 2019

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

artículo científico publicado en 2016

Blood transfusion in hematologic intensive care unit.

artículo científico publicado en 2016

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network

artículo científico publicado en 2015

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

artículo científico publicado en 2017

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

artículo científico publicado en 2016

Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

artículo científico publicado en 2017

Deferasirox and vitamin D improves overall survival in elderly patients with acute myeloid leukemia after demethylating agents failure

artículo científico publicado en 2013

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program

artículo científico publicado en 2016

Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy

artículo científico publicado en 2011

Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma

artículo científico publicado en 2017

Does PET reconstruction method affect Deauville scoring in lymphoma patients?

artículo científico publicado en 2017

Gastrointestinal manifestations in mastocytosis: a study of 83 patients

artículo científico publicado en 2013

Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC).

artículo científico publicado en 2016

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

artículo científico publicado en 2004

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

artículo científico publicado en 2014

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study

artículo científico publicado en 2016

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases

artículo científico publicado en 2012

Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis

artículo científico publicado en 2013

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

artículo científico publicado en 2015

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

artículo científico publicado en 2017

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive

artículo científico

Mast cell leukemia

artículo científico

Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature

artículo científico publicado en 2012

Mast cell sarcoma: new cases and literature review

artículo científico publicado en 2016

Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients

artículo científico publicado en 2016

New insights in the management of patients with hairy cell leukemia

artículo científico

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

artículo científico publicado en 2015

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

artículo científico publicado en 2004

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Relocalization of KIT D816V to cell surface after dasatinib treatment: potential clinical implications

artículo científico publicado en 2012

Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial

artículo científico publicado en 2012

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

artículo científico publicado en 2017

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

artículo científico publicado en 2011

SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes

artículo científico publicado en 2014

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: a French nationwide study

artículo científico publicado en 2020

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

artículo científico publicado en 2016

Thalidomide in advanced mastocytosis

artículo científico publicado en 2008

Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study

artículo científico publicado en 2013

The benefit of induction chemotherapy in patients age > or = 75 years

artículo científico publicado en 2004

The prognostic value of hematogones in patients with acute myeloid leukemia

artículo científico publicado en 2016

Lista de obras de

A French National Survey on Clotting Disorders in Mastocytosis

A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets

Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

Be ever cautious until the truth is proven

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Blood transfusion in hematologic intensive care unit.

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

Deferasirox and vitamin D improves overall survival in elderly patients with acute myeloid leukemia after demethylating agents failure

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program

Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy

Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma

Does PET reconstruction method affect Deauville scoring in lymphoma patients?

Gastrointestinal manifestations in mastocytosis: a study of 83 patients

Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC).

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases

Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive

Mast cell leukemia

Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature

Mast cell sarcoma: new cases and literature review

Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients

New insights in the management of patients with hairy cell leukemia

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

Relocalization of KIT D816V to cell surface after dasatinib treatment: potential clinical implications

Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: a French nationwide study

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells

Thalidomide in advanced mastocytosis

Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study

The benefit of induction chemotherapy in patients age > or = 75 years

The prognostic value of hematogones in patients with acute myeloid leukemia